Deaths averted by COVID-19 vaccination in select Latin American and Caribbean Countries: a modelling study
Savinkina, A.; Weinberger, D.; Toscano, C.; De Oliviera, L. H.
Show abstract
BackgroundThe COVID-19 pandemic has had a significant impact on global health, with millions of lives lost worldwide. Vaccination has emerged as a crucial strategy in mitigating the impact of the disease. This study aims to estimate the number of deaths averted through vaccination in LAC during the first year and a half of vaccination rollout (January 2021 - May 2022). MethodsPublicly available data on COVID-19 deaths and vaccination rates were used to estimate the total number of deaths averted via vaccination in LAC. Using estimates for number of deaths, number of vaccinated, and vaccine effectiveness, a counterfactual estimated number of deaths observed without vaccination was calculated. Vaccine effectiveness estimates were obtained from published studies. The analysis focused on 17 countries in LAC and considered adults aged 18 years and above. FindingsAfter accounting for underreporting, the analysis estimated that over 1.49 million deaths were caused by COVID-19 in the selected countries during the study period. Without vaccination, the model estimated that between 2.10 and 4.11 million COVID-19 deaths would have occurred. Consequently, vaccination efforts resulted in approximately 610,000 to 2.61 million deaths averted. InterpretationThis study represents the first large-scale, multi-center estimate of population-level vaccine impact on COVID-19 mortality in LAC. The findings underscore the substantial impact of timely and widespread vaccination in averting COVID-19 deaths. These results provide crucial support for vaccination programs aimed at combating epidemic infectious diseases in the region and future pandemics. FundingThis study was funded by the Pan-American Health Organization (PAHO).
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Missed childhood immunizations during the COVID-19 pandemic in Brazil: analyses of routine statistics and of a national household survey 96%
- COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery 95%
- Worldwide routine immunisation coverage regressed during the first year of the COVID-19 pandemic 94%
Similar papers in this journal
- Health spending and vaccination coverage in low-income countries 95%
- Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study 94%
- Ethnic disparities in immunisation: analyses of zero-dose prevalence in 64 low- and middle-income countries 94%
Similar papers in this journal
- Time-Varying Effectiveness of Three Covid-19 Vaccines in Puerto Rico 94%
- Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the Omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control study 94%
- Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study 92%
Similar papers in this journal
- COVID-19 vaccine uptake and effectiveness by time since vaccination in the Western Cape province, South Africa: An observational cohort study during 2020-2022 94%
- Effectiveness of the WHO-authorized Covid-19 Vaccines: a Rapid Review of Global Reports till June 30, 2021 93%
- Effectiveness of ChAdOx1 nCoV-19 Corona Virus Vaccine (Covishield™) in preventing SARS-CoV2 infection, Chennai, Tamil Nadu, India, 2021 93%
Similar papers in this journal
- Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study 94%
- Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States 93%
- Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from 12 July 2021 to 6 June 2022: a prospective cohort study 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.